| Ytd | 155.29% | |
| 1y | 315.33% |
| Open | 90.83 | Prev Close | 91.03 | Low | 87.00 | High | 93.61 | Mkt Cap | 7.83B |
| Vol | 1.86M | Avg Vol | 1.89M | EPS | 0.14 | P/E | 628.93 | Forward P/E | 15.53 |
| Beta | 0.57 | Short Ratio | 5.34 | Inst. Own | 78.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 76.52 | 200-d Avg | 46.90 | 1yr Est | 84.88 |
Liquidia, PBF Energy and Forum Energy Technologies pair low beta with positive momentum and growth d
Lenovo Group, Victoria's Secret and Liquidia Corporation are three stocks from very different indust
LQDA heads into its Q2 earnings with Yutrepia driving growth, rising profitability and a self-funded
MORRISVILLE, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharm
Liquidia, Energy Transfer and PBF Energy offer low-beta exposure as oil-driven volatility rises, bac
Liquidia's Yutrepia launch is fueling rapid growth, outperforming United Therapeutics on estimates a
HC Wainwright & Co. analyst Andrew S. Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and ra
Liquidia's Yutrepia is driving strong growth with rapid commercial adoption as the company expands i
On July 13, 2026, Liquidia Corp (LQDA) shares experienced a notable decline of 8.7%, currently price
LQDA's Yutrepia posts a strong commercial debut, but sustaining growth will hinge on standing out in
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help i
Liquidia has surged 129.7% so far in 2026 as Yutrepia gains traction, driving strong sales, profitab
Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? L
LQDA's Yutrepia launch is gaining traction, with $130 million in Q1 sales, rising prescriptions and
Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials,
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad
LQDA, FLXS and AGX screen as low-beta stocks with positive price moves, solid trading volume and com
Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript
Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take
MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharm
On June 08, 2026, Liquidia Corp (LQDA) shares rose 3.4% today, continuing a strong performance withi
MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharm
Wall Street analysts changed outlook on top names. For full view of analyst rating changes, see anal
US stocks rise, Nasdaq up 0.3%. Liquidia Corp (LQDA) beats Q1 expectations, shares rise 15.7%. Other
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s sessi
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average vo
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly